FINWIRES · TerminalLIVE
FINWIRES

KRX:008930

2 stories mentioning KRX:008930Updated 17d ago

Every FINWIRES story that references KRX:008930, newest first.

What's the latest news on KRX:008930?

Asia

Hanmi Pharm Signs $2.31 Billion License Deal for HM17321 with Genentech

Hanmi Science (KRX:008930) said its unit Hanmi Pharm has signed a $2.31 billion license deal with Genentech, granting an exclusive license to research, develop, manufacture, and commercialize HM17321, a long-acting UCN2 analog, worldwide, excluding South Korea.Under the deal, Hanmi Pharm will receive $190 million in upfront payments and is eligible for up to $2.12 billion in milestone payments tied to clinical development, regulatory approval, and commercialization, according to a Thursday filing with the Korean ExchangeHanmi Pharm will also receive tiered royalties based on annual net sales following commercialization, and the deal is subject to applicable administrative procedures and administrative requirements.

KRX:008930
Asia

South Korean Shares Rise to Record High on Chip, AI-related Stock Gains; Hanmi Science Shares Jump Over 4%

South Korean stocks climbed to a new high on Monday, buoyed by strong gains in semiconductor firms and AI-related shares. Shares of major market movers Samsung Electronics (KRX:005930), SK Hynix (KRX:000660), and LG Electronics (KRX:066570) added over 10%, more than 1%, and nearly 30%, respectively, at market close.The Korea Composite Stock Price Index or Kospi rose 312.23 points, or 3.7%, to end at 8,788.38. The Kosdaq decreased by 24.77 points, or 2.3%, to close at 1,050.03.In economic news, South Korea recorded a trade surplus of $26.9 billion in May, a new all-time high, and marking the third straight month of more than $20 billion in trade surplus, the Ministry of Trade, Industry and Energy said in a Monday release.It came as exports increased 53.2% to $87.8 billion from the year-ago period, the sharpest pace of growth since 1984. Imports rose 20.8% to $60.8 billion.Semiconductor exports surged 169.4% to a record $37.16 billion, while non-semiconductor exports increased by 16%. Rising memory chip prices amid increased capital spending by major U.S. technology companies pushed chip exports higher.In corporate news, Hanmi Science (KRX:008930) signed a technology licensing agreement for Sonefpeglutide (HM15912), a short bowel syndrome drug, with Eli Lilly and Co., according to a Monday filing with the Korea Exchange.The technology licensing agreement is worth up to $1.26 billion, including a $75 million upfront payment and up to $1.185 billion in development, regulatory, and commercial milestones, along with royalties based on future sales.Shares of the company rose more than 4% at market close.

^KOSDAQKOSPIKRX:000660KRX:005930KRX:008930KRX:066570

Track with the FINWIRES app suite